↓ Skip to main content

A negative allosteric modulator modulates GABAB-receptor signalling through GB2 subunits.

Overview of attention for article published in Biochemical Journal, January 2016

Mentioned by

twitter
2 X users

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A negative allosteric modulator modulates GABAB-receptor signalling through GB2 subunits.
Published in
Biochemical Journal, January 2016
DOI 10.1042/bj20150979
Pubmed ID
Authors
Abstract

GABAB receptor mediates slow and prolonged synaptic inhibition in the central nervous system, which represents an interesting target for the treatment of various CNS diseases and disorders. Till now, only one activator of GABAB receptor, baclofen, is on the market for the treatment of spasticity. Inhibitors of GABAB receptor such as antagonists show anti-absence seizure activity and pro-cognitive properties. In a search for the allosteric compounds of GABAB receptor, whereas several positive allosteric modulators (PAMs) have been developed, only recently the first negative allosteric modulator (NAM), CLH304a (also named as Compound 14), has been reported. Here we provide further information on the mechanism of action of CLH304a, and also show the possibility to design more NAMs such asCLH391 and CLH393, based on the structure of CLH304a. We first show that CLH304a inhibits the native GABAB receptor activity in cultured cerebellar granule neurons. We then show that CLH304a has inverse agonist property and non-competitively inhibits the effect of agonist, indicating that it binds at a different site than GABA. GABAB receptor is a mandatory heterodimer made of GB1subunits where agonists bind, and GB2 subunits that activates G proteins. By using various combinations made of wild type and/or mutated of GB1 and GB2, we show that CLH304a acts on the heptahelical domain of GB2. These data revealed the possibility to design innovative NAMs acting in the HD of GB2, offering novel possibilities for therapeutic intervention based on GABAB receptor inhibition.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 5 22%
Student > Ph. D. Student 4 17%
Student > Bachelor 2 9%
Researcher 2 9%
Lecturer 1 4%
Other 2 9%
Unknown 7 30%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 13%
Medicine and Dentistry 3 13%
Neuroscience 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Chemistry 2 9%
Other 2 9%
Unknown 8 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2016.
All research outputs
#27,900,012
of 34,559,526 outputs
Outputs from Biochemical Journal
#15,837
of 16,981 outputs
Outputs of similar age
#339,139
of 450,775 outputs
Outputs of similar age from Biochemical Journal
#49
of 60 outputs
Altmetric has tracked 34,559,526 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,981 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,775 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.